SCHEER - UPDATE of the GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Information
Type
Expert Opinion
Regulated products
Medical Devices
Published
June 17, 2024
Last updated
June 17, 2024
Description
SCHEER - UPDATE of the GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Tags
Organization
Country / Region
European Union
License
Creative Commons Attribution 4.0